MIRA
What one share of MIRA Pharmaceuticals holds
Pharmaceutical Preparations
Pharmaceuticals, Inc. (NASDAQ: MIRA, the “Company”, “we”, “us”) is a clinical-stage pharmaceutical development company advancing a pipeline of novel oral therapeutics targeting neurologic, neuropsychiatric, metabolic, and addiction-related disorders.
MIRA Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.26 |
|---|---|
| Cash and investments | $0.09 |
| Book value | $0.19 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | — | −$0.40 | — | −$0.32 | — | −$0.04 |
| 2023 | — | −$0.86 | — | −$0.33 | — | $0.30 |
| 2024 | — | −$0.51 | — | −$0.36 | — | $0.13 |
| 2025 | — | −$1.35 | — | −$0.20 | — | $0.25 |